Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50014702
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50123521([2'-(2-Pyridin-2-yl-ethylcarbamoyl)-biphenyl-2-ylm...)
Affinity DataIC50: 200nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146386(5-Methoxy-N-((S)-1-phenyl-propyl)-2-(toluene-4-sul...)
Affinity DataIC50: 500nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146378(N-Benzyl-N-(1H-pyrazol-3-ylmethyl)-2-(toluene-4-su...)
Affinity DataIC50: 500nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146403(N-((S)-1-Phenyl-propyl)-2-(quinoline-8-sulfonylami...)
Affinity DataIC50: 600nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146395(2-(4-Methoxy-benzenesulfonylamino)-N-((S)-1-phenyl...)
Affinity DataIC50: 600nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146402(N-Benzyl-N-(1-methyl-1H-imidazol-2-ylmethyl)-2-(to...)
Affinity DataIC50: 700nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146377(N-((S)-1-Phenyl-propyl)-2-(toluene-4-sulfonylamino...)
Affinity DataIC50: 700nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146381(N-Benzyl-N-pyridin-3-ylmethyl-2-(toluene-4-sulfony...)
Affinity DataIC50: 700nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146377(N-((S)-1-Phenyl-propyl)-2-(toluene-4-sulfonylamino...)
Affinity DataIC50: 700nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146382(N-Furan-2-ylmethyl-N-(1-methyl-1H-imidazol-2-ylmet...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146379(N-(Cyclopropyl-phenyl-methyl)-2-(toluene-4-sulfony...)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146398(2-(3-Methyl-butane-1-sulfonylamino)-N-((S)-1-pheny...)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146380(N-Benzyl-N-cyclopropylmethyl-2-(toluene-4-sulfonyl...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146376(N,N-Bis-pyridin-3-ylmethyl-2-(toluene-4-sulfonylam...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146394(N-((R)-1-Phenyl-propyl)-2-(toluene-4-sulfonylamino...)
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146392(2,4-Dichloro-N-indan-1-yl-5-(3-methyl-butylsulfamo...)
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146401(N-((S)-1-Phenyl-propyl)-2-(propane-1-sulfonylamino...)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146389(N-(1-Phenyl-ethyl)-2-(toluene-4-sulfonylamino)-ben...)
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146391(2-(Naphthalene-1-sulfonylamino)-N-((S)-1-phenyl-pr...)
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146396(5-Acetyl-N-((S)-1-phenyl-propyl)-2-(toluene-4-sulf...)
Affinity DataIC50: 3.80E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146383(N-Benzyl-2-(toluene-4-sulfonylamino)-benzamide | C...)
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146385(N-Benzyl-N-ethyl-2-(toluene-4-sulfonylamino)-benza...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146400(N-Benzyl-5-chloro-2-(4-chloro-benzenesulfonylamino...)
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146393(N-((S)-1-Phenyl-propyl)-2-(4-trifluoromethyl-benze...)
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146388(2-(4-Chloro-benzenesulfonylamino)-5-fluoro-N-((S)-...)
Affinity DataIC50: 6.50E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146384(N-Phenethyl-2-(toluene-4-sulfonylamino)-benzamide ...)
Affinity DataIC50: 6.70E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146387(2-Benzenesulfonylamino-N-((S)-1-phenyl-propyl)-ben...)
Affinity DataIC50: 6.90E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146397(N-Benzyl-N-(3-imidazol-1-yl-propyl)-2-(toluene-4-s...)
Affinity DataIC50: 8.50E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146399(2-(Isoquinoline-5-sulfonylamino)-N-((S)-1-phenyl-p...)
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50146390(2-Ethanesulfonylamino-N-((S)-1-phenyl-propyl)-benz...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory effect against human voltage-gated potassium channel subunit Kv1.5 expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed